ATR and colorectal carcinoma: Similar results have been observed in models of colorectal carcinomas treated with curaxins (small molecules that interfere with DNA-histone interactions) [48], as well as in models of HPV-driven tumors responding to RT plus ATR serine/threonine kinase (ATR) inhibitors [49].